Biopolym. Cell. 1998; 14(3):203-209.
Structure and Function of Biopolymers
Structural and functional studies of cardiac tropomyosin as; autoantigen at dilated cardiomyopathy
- Institute of Molecular Biology and Genetics, NAS of Ukraine
150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680
Abstract
Tropomyosin have been purified to homogeneity from normal, and affected by dilated cardiomyopathy (DCMP) human myocardium and from skeletal muscle as well. The molecular masses of both preparations of cardiac tropomyosins were identical. The immuno-screening of DCMP patients sera by EUSA method have shown the presence of autoantibodies directed against cardiac tropomyosin in the limited number of sera. No immunoreactivity have been detected against skeletal tropomyosin. Western blot analysis detected any linear determinants in tropomyosin molecule under denaturating conditions. We suggest that cardiac tropomyosin doesn't undergoes sufficient structural changes at dilated cardiomyopathy progression.
Full text: (PDF, in Russian)
References
[1]
Rose NR, Neumann DA, Herskowitz A. Autoimmune myocarditis: concepts and questions. Immunol Today. 1991;12(8):253-5.
[2]
Schultheiss HP, Bolte HD. Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol. 1985;17(6):603-17.
[3]
Neumann DA, Burek CL, Baughman KL, Rose NR, Herskowitz A. Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol. 1990;16(6):839-46.
[4]
Limas CJ, Limas C. Immune-mediated modulation of beta-adrenoceptor function in human dilated cardiomyopathy. Clin Immunol Immunopathol. 1993;68(2):204-7.
[5]
Limas CJ, Limas C, Kubo SH, Olivari MT. Anti-beta-receptor antibodies in human dilated cardiomyopathy and correlation with HLA-DR antigens. Am J Cardiol. 1990;65(7):483-7.
[6]
Rose NR, Herskowitz A, Neumann DA, Neu N. Autoimmune myocarditis: a paradigm of post-infection autoimmune disease. Immunol Today. 1988;9(4):117-20.
[7]
De Scheerder I, De Buyzere M, Algoed L, De Lange M, Delanghe J, Bogaert AM, et al. Characteristic anti-heart antibody patterns in post-cardiac injury syndrome, endocarditis and acute myocarditis. Eur Heart J. 1987;8(suppl J):237-8.
[8]
Bobik VI, Veberov AV, Ryabenko DV, Dubrovskaya GV, Rodnin NV, Sidorik LL. The purification of the main tissue-specific antigens from the normal and effected by dilatative cardiomyopathia human heart. Biopolym Cell. 1993; 9(6):63-6.
[9]
Sidorik LL, Rodnin NV, Bobyk VI, Ryabenko DV, Veberov AV, Tkachenko TYu, Matsuka GKh. Investigation of autoantibodies directed against tissue-specific myocardial antigens in dilated cardiomyopathy. Biopolym Cell. 1995; 11(1):81-6.
[10]
Bolgarin RN, Rodnin NV, Sidorik LL. Autoantibodies to tryptophanyl-tRNA-synthetase in systemic autoimmune diseases. Mol Biol (Mosk). 1998;32(4):745-9.
[11]
Khanna AK, Nomura Y, Fischetti VA, Zabriskie JB. Antibodies in the sera of acute rheumatic fever patients bind to human cardiac tropomyosin. J Autoimmun. 1997;10(1):99-106.
[12]
Liao L, Sindhwani R, Rojkind M, Factor S, Leinwand L, Diamond B. Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J Exp Med. 1995;181(3):1123-31.
[13]
Kaplan MH, Svec KH. Immunologic relation of Streptococcal and tissue antigens. III. Presence in human sera of Streptococcal antibody cross-reactive with heart tissue. Association with Streptococcal infection, rheumatic fever, and glomerulonephritis. J Exp Med. 1964;119:651-66.
[14]
Muthuchamy M, Grupp IL, Grupp G, O'Toole BA, Kier AB, Boivin GP, Neumann J, Wieczorek DF. Molecular and physiological effects of overexpressing striated muscle beta-tropomyosin in the adult murine heart. J Biol Chem. 1995;270(51):30593-603.
[15]
Ross RS, Bulkley BH, Hutchins GM, Harshey JS, Jones RA, Kraus H, Liebman J, Thorne CM, Weinberg SB, Weech AA, Weech AA Jr. Idiopathic familial myocardiopathy in three generations: a clinical and pathologic study. Am Heart J. 1978;96(2):170-8.
[16]
Mestroni L, Miani D, Di Lenarda A, Silvestri F, Bussani R, Filippi G, Camerini F. Clinical and pathologic study of familial dilated cardiomyopathy. Am J Cardiol. 1990;65(22):1449-53.
[17]
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
[18]
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680-5.
[19]
Mische SM, Manjula BN, Fischetti VA. Relation of streptococcal M protein with human and rabbit tropomyosin: the complete amino acid sequence of human cardiac alpha tropomyosin, a highly conserved contractile protein. Biochem Biophys Res Commun. 1987;142(3):813-8.
[20]
Matsiota P, Druet P, Dosquet P, Guilbert B, Avrameas S. Natural autoantibodies in systemic lupus erythematosus. Clin Exp Immunol. 1987;69(1):79-88.
[21]
Ternynck T, Bleux C, Gregoire J, Avrameas S, Kanellopoulos-Langevin C. Comparison between autoantibodies arising during Trypanosoma cruzi infection in mice and natural autoantibodies. J Immunol. 1990;144(4):1504-11.
[22]
Fiorito S, Autore C, Fragola PV, Purpura M, Cannata D, Sangiorgi M. HLA-DR3 antigen linkage in patients with hypertrophic obstructive cardiomyopathy. Am Heart J. 1986;111(1):91-4.
[23]
Kaplan MH, Frengley JD. Autoimmunity to the heart in cardiac disease. Current concepts of the relation of autoimmunity to rheumatic fever, postcardiotomyand postinfarction syndromes and cardiomyopathies. Am J Cardiol. 1969;24(4):459-73. Review.
[24]
Zabriskie JB. Rheumatic fever: the interplay between host, genetics, and microbe. Lewis A. Conner memorial lecture. Circulation. 1985;71(6):1077-86.
[25]
Fenderson PG, Fischetti VA, Cunningham MW. Tropomyosin shares immunologic epitopes with group A streptococcal M proteins. J Immunol. 1989;142(7):2475-81.
[26]
Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today. 1991;12(5):154-9.
[27]
Movsesian MA, Bristow MR, Krall J. Ca2+ uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy. Circ Res. 1989;65(4):1141-4.